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Abstract A synthetic heptaphosphopeptide comprising the fully 
pbosphorylated carboxyl terminal pbosphorylation region of bo- 
vine rbodopsin, residues 330-348, was found to induce a confor- 
mational change in bovine arrestin. This caused an alteration of 
the pattern of limited proteolysis of arrestin similar to that in- 
duced by binding pbospborylated rbodopsin or heparin. Unlike 
heparin, the phosphopeptide also induced light-activated binding 
of arrestin to both unphospborylated rhodopsin in disk mem- 
branes as well as to endoproteinase Asp-N-treated rbodopsin (des 
330-348). These findings suggest hat one function of phosphoryl- 
ation of rhodopsin is to activate arrestin which can then bind to 
other regions of the surface of the photoactivated rhodopsin. 
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transient chemical change associated with the process [5]. The 
effect of arrestin binding can also be observed by its inhibition 
of light-stimulated cGMP-phosphodiesterase ctivity. 
It has been recognized that phosphorylation f the activated 
receptor greatly enhances arrestin binding, and that binding is 
minimal to the unphosphorylated receptor [4,6-8]. In the pres- 
ent work, we show that in the presence of a synthetic 
phosphorylated peptide from rhodopsin's carboxyl-terminal se- 
quence, arrestin can bind to photoactivated unphosphorylated 
rhodopsin. We demonstrate that binding of the phosphopep- 
tide to arrestin causes a change in the conformation of arrestin, 
and that it is this new conformation of arrestin that is capable 
of binding to photoactivated rhodopsin. Other G-protein- 
linked receptors may similarly activate their corresponding ar- 
restins which can then bind to other regions of the surface of 
the activated receptor. 
1. Introduction 
Arrestins are a class of proteins that participate in the deac- 
tivation of G-protein-coupled receptors. Once such a receptor 
has been activated it can activate a G-protein that can in turn 
influence the activity of a cell-specific target protein. The recep- 
tor is turned o f f -  prevented from continuing to activate its 
G-protein - via phosphorylation bya protein kinase and subse- 
quent binding of an arrestin. In a well-studied system of this 
kind, the visual receptor rhodopsin is photoactivated, 
phosphorylated by rhodopsin kinase, and bound by retinal 
arrestin (reviewed in [I]). 
Retinal arrestin is a 45 kDa protein that has been best studied 
from cattle retinal rod cells (reviewed in [2]). Arrestin has been 
shown to occur widely phylogenetically throughout the verte- 
brates and invertebrates. The binding of arrestin to membrane- 
bound photoactivated phosphorylated rhodopsin has been de- 
tected directly by centrifugation [3], by a column binding assay 
[4], and spectrophotometrically [5]. Upon binding, arrestin sta- 
bilizes rhodopsin's photoproduct Metarhodopsin II. There is 
a high activation energy for this binding that indicates a large 
*Corresponding author. Fax: (1) (904) 392 0573. 
Abbreviations: cGMP, guanosine 3': 5'-cyclic monophosphate; DEAE- 
cellulose, diethylaminoethyl cellulose; DTT, dithiothreitol; EDTA, 
(ethylenedinitrilo)tetraacetic acid; HEPES, (N-[hydroxyethyl]piper- 
azine-N'-[2-ethanesulfonic acid]); PDE, cGMP-phosphodiester- 
ase; PMSF, phenylmetbylsulfonyl fluoride; ROS, rod outer segment; 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide g l electrophore- 
sis; 7P[330-348], rhodopsin peptide of sequence 330-348 in which all 
seven serine and threonine residues are phosphorylated. 
2. Materials and methods 
2.1. Purification of bovine arrest& 
Arrestin was purified from bovine retinas by a modification of the 
method of Buczylko and Palczewski [9]. The extract containing arrestin 
was submitted to DEAE-cellulose chromatography at pH 7.0 rather 
than at pH 7.5. The column was washed with 1 liter of the buffered 15 
mM NaCI. Arrestin was then eluted, using 1 liter of buffered 55 mM 
NaC1, directly onto the heparin-agarose column. Arrestin was eluted 
from the heparin-agarose column with a phytic acid gradient, dialyzed, 
again loaded on a heparin-agarose column and eluted with 400 mM 
NaC1 in buffer as previously described [9]. These modifications shorten 
preparation time by 1 day and result in production of arrestin in high 
yield and purity. Approximately 25 mg of purified arrestin can be 
obtained from 100 bovine retinas. 
2.2. Preparation of bovine rod outer segment membranes 
All operations were carried out at 4°C under dim red light unless 
otherwise specified. Bovine retinas (Lawson, Inc., Lincoln, NE) were 
used to prepare rod cell outer segments (ROS) by sucrose gradient 
centrifugation [10]. Membranes were stored frozen prior to use. 
2.3. Phosphorylation of rhodopsin 
ROS were suspended in 100 mM potassium phosphate, 1 mM MgCI2, 
0.1 mM EDTA, 1 mM DTT (pH 7.0) to a final concentration f 13.2 
,uM rhodopsin. The ROS were brought o 30°C and ATP was added 
to 3 mM. The sample was illuminated for 1 h at 30°C with a 150 watt 
flood lamp from about 15 cm. The ROS were regenerated by adding 
a 3-fold molar excess of 11-cis retinal and incubating in the dark over- 
night [10]. 
2.4. Preparation of bovine ROS disk membranes 
ROS membranes were prepared as above. Intact disk membranes 
were prepared from these ROS by Ficoll flotation [11]. 
2.5. Limited proteolysis of rhodopsin 
Membrane-bound rhodopsin lacking its carboxyl-terminal sequence 
330 348 was prepared by digestion of ROS disk membranes with 
0014-5793195/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
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endoproteinase Asp-N [12]. Conversion of full-length rhodopsin to a 
lower molecular weight was confirmed by SDS-PAGE. 
2.6. Limited proteolysis of arrestin 
The limited proteolysis was carried out using the method of 
Palczewski et al. [13]. Arrestin at 0.5 mg/ml in 10 mM HEPES, 100 mM 
NaCI, 1 mM DTT, 0.1 mM CaC12 (pH 7.5) was digested with 3% 
TPCK-treated trypsin (Sigma) with no additions, with heparin (100 
/2g/ml), with phosphopeptide (1.0 mg/ml), or with unphosphorylated 
peptide 330-348 (1.0 mg/ml). Samples were withdrawn at 10 min after 
the addition of trypsin with the 0 time sample taken before adding 
trypsin. The digested aliquots were mixed with an equal volume of 20 
mM benzamidine and 1 mM PMSF in the reaction buffer without DTT 
and with 0.5% isopropyl alcohol (used to dissolve the PMSF). The 
denaturing buffer was added and the samples were incubated at room 
temperature for 30 rain. The samples were immediately submitted to 
SDS-PAGE. 
2. 7. Binding of arrestin to membrane-bound rhodopsin assessed by gel 
filtration 
Twenty chromatography columns (Poly-Prep, Bio-Rad), supported 
on an acrylic rack, were filled with 2.0 ml of Sepharose 2B resin [14]. 
Columns were equilibrated with phosphate reaction buffer (100 mM 
sodium phosphate (pH 7.0), 100 mM NaC1, 1 mM MgCI:, 0.1 mM 
EDTA, 0.5 mM DTT). All steps of the reaction and analysis were 
performed at room temperature. ROS disk membranes for the binding 
studies were suspended inthe reaction buffer at a rhodopsin concentra- 
tion of 50/2M. Prior to use the ROS disk membranes were sonicated 
under dim red light under a stream of N2 for 2 min (Microzoon ultra- 
sonic cell disrupter, Heat Systems-Ultrasonics, Inc., NY, using a 2 mm 
sonicator tip, at 45% maximum output). Reaction mixtures (200/21) 
were prepared containing a final rhodopsin concentration f 10/2M and 
measured amounts of arrestin and other effectors. Illuminated reaction 
mixtures were exposed to flood lights at 60 cm for 2 min. Dark reaction 
mixtures were held in the dark for the same time. All experimental 
samples were submitted to gel filtration at the same time. Immediately 
following illumination, each reaction mixture was applied to a column 
under dim red light and the eluant was discarded. Phosphate buffer (400 
/21) was carefully applied, allowed to drain, and the eluant discarded. 
Subsequent 500/21 aliquots of buffer were applied and the eluants were 
collected and examined by SDS-PAGE. Membranes and bound ar- 
restin were found in the first eluant collected while the unbound arrestin 
was eluted in later fractions. 
2.8. SDS-PAGE 
SDS-PAGE was performed under non-reducing conditions accord- 
ing to the method of Laemmli [15]. Aliquots of samples from the 
Sepharose columns were mixed 1 : 1 with 2x concentrated SDS-PAGE 
sample buffer and allowed to denature for 30 min at room temperature 
prior to applying 50/21 aliquots for SDS-PAGE. Acrylamide slab gels 
(12%, 1.5 mm thickness, containing 10 wells) were run in a minigel 
apparatus (Model SE 250, Hoeffer Scientific) for 1 h at 150 V. Gels were 
stained overnight with a filtered solution of Coomassie brilliant blue 
R-250 (Fisher) in 1:4.5:4.5 (v/v/v) acetic acid/methanol/water (4 h to 
overnight). Gels were destained using 1 : 3 : 6 (v/v/v) acetic acid/metha- 
nol/water. 
2.9. Densitometry of SDS-PAGE gels 
Densitometry was performed on destained SDS-PAGE gels on an 
electronically stabilized light table using a Microscan 1000 (Technology 
Resources, Inc.) fitted with a linear photodiode array to digitize the 
image. The digitized image was visualized and stored using TriScan 
software, and quantified using NIH Image Analysis oftware (version 
153 nonfpu). 
2.10. Peptide synthesis, purification and characterization 
Peptides were synthesized from Boc-amino acids by standard solid- 
phase methods using an automated synthesizer (Applied Biosystems 
431A). Peptides ynthesized were residues 330-348 from bovine rho- 
dopsin sequence which comprises the carboxyl terminal phosphoryla- 
tion site - DDEASTTVSKTETSQVAPA. The fully phosphorylated 
phosphopeptide was synthesized by solid phase methods using t-boc 
phosphono esters of serine and threonine as previously described 
[16,17]. Preparative purification of peptides was achieved by reversed 
phase HPLC, using a 0~0% gradient ofacetonitrile n 0.05% acetic acid 
on a Partisil 10 ODS-3 column (Whatman). Peptides were examined by 
analytical HPLC for purity and were determined to have the correct 
amino acid composition by acid hydrolysis with 6 N HCI followed by 
amino acid analysis. Molecular weight was verified by time-of-flight 
mass spectral analysis (Vestec). 
3. Results and discussion 
The most characteristic property of retinal arrestin is its 
light-dependent binding to phosphorylated rhodopsin [3,18]. 
Arrestin exhibits only negligible binding to phosphorylated 
rhodopsin in the dark, and its binding is greatly enhanced when 
rhodopsin is photoactivated (Fig. 1, lanes 1,2; [4,7,18]). Not 
only is photoactivation of rhodopsin necessary, phosphoryla- 
tion is also required. Unphosphorylated rhodopsin in ROS disk 
does not bind arrestin, and binding is only slightly enhanced 
when rhodopsin is illuminated (Fig. 1, lanes 3,4). However, 
when the synthetic phosphopeptide that represents rhodopsin's 
carboxyl-terminal phosphorylation region (residues 330-348) is 
present, arrestin's binding to photoactivated rhodopsin is con- 
siderably enhanced (Fig. 1, lanes 5,6), reaching more than 50% 
of the level of binding to photoactivated phosphorylated rho- 
dopsin (Fig. 1, lane 2). It is important that the rhodopsin syn- 
thetic peptide be phosphorylated. When unphosphorylated 
peptide 330-348 is incubated with arrestin and rhodopsin, it 
fails to stimulate light-dependent binding of arrestin (Fig. 1, 
lanes 7,8). These observations suggest hat the free synthetic 
phosphopeptide of rhodopsin is able to substitute for the role 
of the phosphorylated carboxyl-terminal of membrane-bound 
rhodopsin in stimulating arrestin to bind to photoactivated 
rhodopsin. In fact, rhodopsin's carboxyl-terminal region can be 
eliminated without effect in these experiments as long as the 
phosphopeptide is present. Rhodopsin, whose carboxyl-termi- 
nal 330-348 has been removed by endoproteinase Asp-N diges- 
tion, binds arrestin in a light-dependent manner in the presence 
of the phosphopeptide (Fig. 1, lanes 9 12). Heparin and phytic 
acid, acidic compounds that also bind to arrestin [13], do not 
promote binding to photoactivated unphosphorylated rhodop- 
sin (data not shown). The free phosphopeptide is not as effec- 
tive as the rhodopsin-bound phosphopeptide in promoting ar- 
restin binding (compare Fig. 1, lanes 2 and 6), presumably due 
to the peptide's ability to dissociate from the complex. (We have 
found that performing this binding assay on a column preequil- 
ibrated with phosphopeptide increases the amount of arrestin 
binding, but limited phosphopeptide availability precludes this 
method for routine analysis.) 
The amount of phosphorylated peptide required to cause 
arrestin binding to photoactivated rhodopsin was determined 
using the column binding assay over a range of phosphopeptide 
concentrations (Fig. 2). The amount of arrestin bound to a 
standard amount of rhodopsin was measured by densitometry 
of the stained SDS-polyacrylamide gel. The Ks0 for the 
phosphopeptide was determined to be 36 I2M at 6.4/2M ar- 
restin. 
It is reasonable to propose that the rhodopsin phosphopep- 
tide achieves its effect by binding to arrestin and changing 
arrestin's conformation. We investigated this hypothesis by 
investigating the effect of the phosphopeptide on the limited 
proteolysis of arrestin. When arrestin binds to photoactivated 
phosphorylated rhodopsin or to heparin, the pattern of limited 
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Fig. 1. Binding of arrestin to light-activated unphosphorylated rhodopsin in the presence ofrhodopsin's heptaphosphopeptide. Sonicated ROS disk 
membranes containing rhodopsin were incubated inthe presence ofarrestin as described insection 2. The reaction mixture was submitted toSepharose 
2B column chromatography and the void volume containing the rhodopsin vesicles and protein bound to them was collected and submitted to 
SDS-PAGE. Coomassie-blue stained gels from a representative setof 12 experiments are shown in the top panel. The conditions for each experiment 
are listed in the table in the central panel below each lane: the presence (+) or absence (-) of rhodopsin in ROS disk membranes, phosphorylated 
rhodopsin in ROS, endoproteinase Asp-N-digested rhodopsin i  ROS disk membranes, light, synthetic rhodopsin peptide [330-348], phosphorylated 
peptide 7P[330-348]. The bottom panel shows the amount of arrestin bound to rhodopsin as determined bygel densitometry (bars indicate standard 
error of the mean for between 4 and 10 samples). 
proteolysis of arrestin by trypsin is altered [13]. We have exam- 
ined the effect of the phosphopeptide on arrestin by limited 
proteolysis. Arrestin was first digested with trypsin either with 
no additions (Fig. 3, lane 2) or in the presence of 
unphosphorylated peptide 330-348 (Fig. 3, lane 3). Virtually 
identical patterns were obtained, consistent with the conclusion 
that the unphosphorylated peptide has no effect on arrestin's 
conformation. This is in contrast with the results obtained 
in the presence of heparin (Fig. 3, lane 4) or phosphopeptide 
(Fig. 3, lane 5). Here one observes an increase in the rate of 
proteolysis, as shown by the more rapid disappearance of full- 
length arrestin, and a decrease in the number of different diges- 
tion products. The pattern of limited proteolysis of arrestin in 
the presence of photoactivated phosphorylated rhodopsin in 
ROS was similar to that obtained with phosphopeptide and 
heparin (data not shown; [13]). 
In conclusion, the data presented support the hypothesis that 
the phosphopeptide induces a conformational change in 
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Fig. 2. Effect of amount of rhodopsin heptaphosphopeptide 330 348 
on the binding of arrestin to photoactivated rhodopsin. The amount of 
arrestin bound per amount of rhodopsin i  column binding experiments 
(as determined from gel densitometry) is plotted vs. the amount of 
7P[330-348] in the reaction mixture. In these experiments the columns 
were not pre-equilibrated with phosphopeptide. Inset: The same data 
is plotted with log [phosphopeptide] onthe X-axis. 
arrestin. This conformational change is similar to that induced 
by the polyanion heparin so that our data are in reasonable 
accord with the model proposed by Palczewski and colleagues 
[13]. However, the current data indicate that only the 
phosphopeptide causes the conformational change that leads 
to enhanced binding of arrestin to photoactivated 
u~jghosphorylated rhodopsin. The phosphopeptide also in- 
duces binding to photoactivated ndoproteinase Asp-N treated 
lane 1 2 3 4 5 MW 
arrestin 
- 94kDa 
- 67kDa 
- 43kDa 
- 30kDa 
Fig. 3. Limited proteolysis of arrestin with TPCK-treated trypsin in the 
presence of unphosphorylated peptide 330-348, heptaphosphopeptide 
(330-348), or heparin. Samples from the limited proteolysis of arrestin 
were taken at the indicated times (see section 2) and submitted to 
SDS-PAGE. Undigested arrestin isshown in lane 1. Limited proteolysis 
for 10 min of: arrestin only (lane 2); arrestin plus unphosphorylated 
330-348 peptide (lane 3); arrestin plus heparin (lane 4); arrestin plus 
7P[330-348] (lane 5). 
rhodopsin, a modified rhodopsin that is lacking the phospho- 
rylation region (330-348). This demonstrates that the 
phosphorylated region of rhodopsin is not required per se for 
binding arrestin. The phosphorylated region of photoactivated 
rhodopsin appears to serve the purpose of promoting a confor- 
mational change in arrestin that enables arrestin to recognize 
and bind to other regions of photoactivated rhodopsin. Such 
regions appear to include rhodopsin's third cytoplasmic loop 
and possibly its first cytoplasmic loop [14]. By analogy, one may 
suggest hat one function for the phosphorylation of other 
G-protein-linked receptors is to promote binding of their re- 
spective arrestins. 
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